The challenge is before us...
"Depression is the Cancer of the 21st Century"
World Health Organization
Over 19 million Americans experience a depressive illness each year with many/most of these going undiagnosed and untreated. The tragedy of this social and economic burden
[2000 estimated cost of $83.1 billion] on individuals and the healthcare system is even more unfortunate because of the fact that many of these patients have regular contact with the healthcare system.
Untreated depression for Corporate America's employers is costly at
$77.6 billion. Recent studies show the economic burden breakdown for employers to include $
26.1 billion for direct medical costs. In addition, depressed workers cost their employers
$51.5 billion a year in lost productive time! The economic evidence is clear: employees that are NOT
happy and NOT
healthy -- account for
$36.2 billion in absenteeism costs and
another $15.3 billion in presenteeism costs, i.e., poor work performance.
The high cost of this disease is compounded by the fact that studies have shown that 25-40% of patients with a chronic disease like asthma, COPD, congestive heart disease and diabetes are clinically depressed, contributing to the difficult of managing their physical illness. The burden of depression on our society will be further exacerbated by the fact that one of the fastest growing segments of our society, our baby boomers, are more likely to suffer from depression. In a 4-year study of elderly enrollees in HMOs only 12-25% of patients with clinically significant depressive symptoms received treatment for depression. With the passage of the Medicare Prescription Drug Legislation and the inclusion of disease management in the legislation provides and opportunity to bring together healthcare professionals from different sectors of our industry to more proactive address the barriers that prevent the optimizing of care for depressed patients.
The large gap between best care and usual treatment for depression and the
growing recognition of disease management as a viable strategy for the treatment of chronic disease have created the impetus for the development of this
1st Annual Integrated Healthcare Leadership Summit: Co-Morbid Depression and Chronic Illness.